High preoperative serum carcinoembryonic antigen (CEA) levels have been well investigated and found to be associated with poor prognosis in patients with colorectal cancer (CRC). However, it has been observed that the outcome varies after curative resection, along with postoperative serum CEA levels; some patients continue to have high postoperative serum CEA levels while postoperative CEA levels return to normal in others. The purpose of this study was to determine the prognostic significance of postoperative serum CEA levels in CRC patients with high preoperative serum CEA levels. Between January 2002 and December 2004, 423 CRC patients underwent operation in our hospital; 181 (42.8%) had high preoperative serum CEA levels and were enrolled in this study. Among the 181 patients, 165 patients had curative resection; the remaining 16 had stage IV disease, so they underwent palliative surgery and were subsequently excluded from analysis. Pre-and postoperative serum CEA levels were measured and analyzed. All patients had curative resection and were divided into two groups according to postoperative serum CEA levels: one group comprised patients with postoperative serum CEA ≥ 5 ng/mL (n = 80) and the other group comprised patients with postoperative serum CEA levels < 5 ng/mL (n = 85). Postoperative serum CEA levels were significantly related to location of primary tumors (p = 0.042), lymph node metastases (p = 0.009), TNM stage (p = 0.001), and postoperative relapse (p = 0.004). The results of multivariate analysis showed that both lymph node metastases and high postoperative serum CEA levels (≥ 5 ng/mL) were independent prognostic factors for CRC patients after curative resection. Postoperative serum CEA levels can be a single independent prognostic determinant in CRC patients with high preoperative serum CEA levels. Intensive follow-up and adjuvant therapy may be necessary in CRC patients who continue to have high postoperative serum CEA levels even after curative resection.
Carcinoembryonic antigen (CEA) is an intracellular protein that normally exists in the embryonic and fetal gut, liver, pancreas, and some adult organs [1] . It is elevated in approximately 40% of colorectal cancers (CRCs) [2] and is the most commonly applied tumor marker in CRCs since it was first mentioned in 1965 [3] . CEA has been well investigated, and it has been demonstrated that CRC patients with high preoperative serum CEA levels are associated with an advanced tumor stage, incidence of recurrence and survival [2, [4] [5] [6] [7] [8] [9] [10] [11] . However, prognosis varies in patients with high preoperative serum CEA levels after curative surgery; meanwhile, CEA levels differ after curative surgery as well. Among CRC patients with high preoperative serum CEA levels, there should be some factors that can be used to predict the outcome.
In this study, we retrospectively analyzed stage I-III CRC patients with high preoperative serum CEA levels, and postoperative serum CEA levels were also measured and analyzed after curative surgery.
MATERIALS AND METHODS

Patients
Between January 2002 and December 2004, 423 CRC patients underwent operation in our hospital, of whom 181 (42.8%) had preoperative CEA levels ≥ 5 ng/mL and were included in this study. Among the 181 patients, 165 underwent curative resection; the remaining 16 patients had stage IV disease, so they underwent palliative surgery and were subsequently excluded from analysis.
Preoperative serum CEA was sampled within 1 week before operation, and postoperative serum CEA was obtained at least 4 weeks after operation [12] . Serum CEA levels were determined by means of an enzyme immunoassay test kit (DPC Diagnostic Product Co., Los Angeles, CA, USA) with the upper limit of normal set at 5 ng/mL according to the manufacturer's instructions.
Statistical analysis
All data were analyzed using SPSS version 11.5 (SPSS Inc., Chicago, IL, USA). The χ 2 test was used to compare the clinicopathologic parameters between groups with postoperative serum CEA levels ≥ 5 ng/mL and postoperative serum CEA levels < 5 ng/mL. The cumulative survival rates were calculated by the Kaplan-Meier method, and the differences in survival rates were analyzed by log-rank test. The multivariate analysis of independent prognostic factors for postoperative relapse was determined using multivariate logistic regression analysis. A probability of p < 0.05 was considered to be statistically significant.
RESULTS
Of the 165 patients included in the analysis, 81 were male and 84 were female, mean age was 67. Table 1 .
In CRC patients with abnormal preoperative serum CEA levels, serum CEA remained high after curative resection in some patients, but returned to normal in other patients. This result was further divided into two groups according to postoperative serum CEA levels: ≥ 5 ng/mL (high CEA group) and < 5 ng/mL (low CEA group). There were 80 (48.5%) patients with postoperative serum CEA levels ≥ 5 ng/mL and 85 (51.5%) with postoperative serum CEA levels < 5 ng/mL. Overall, the incidence of postoperative serum CEA levels ≥ 5 ng/mL was 18.9% (of 423 CRC patients).
Postoperative serum CEA levels were related to the location of primary tumors (p = 0.042), lymph node (Table  2) . Meanwhile, the overall survival rate of the two groups was significantly different (p = 0.0131). Patients in the low postoperative serum CEA group had a better overall survival rate than those in the high postoperative serum CEA group (Figure) . Multivariate analysis of the variables listed in Table 2 showed that both lymph node metastases (p = 0.028) and high postoperative serum CEA levels (p = 0.006) were independent prognostic factors ( Table 3) .
DISCUSSION
It has been reported that high preoperative serum CEA levels are associated with a poor prognosis [2, 4, 9, 11, 13] . However, the prognostic significance of postoperative serum CEA levels have seldom been discussed or investigated. Postoperatively, some CRC patients continue to have high serum CEA levels, whereas others have serum CEA levels return to within a normal range. The differences can be attributed to several factors. We found that the location of the primary tumor, lymph node metastases, and TNM stage were significantly related to high postoperative serum CEA levels. The higher incidence of postoperative serum CEA levels in the colon than in the rectum may be associated with the increased incidence of distant metastases in patients with colon cancer and even greater incidence of local recurrence in those with rectal cancer [14] , although the exact reasons are unclear and require further investigation. In addition, postoperative serum CEA levels ≥5 ng/mL were significantly correlated with the presence of lymph node metastases, more advanced tumor stage, and postoperative relapse. Lymph node metastases, together with advanced TNM stage, are well known to be associated with prognosis and determine the treatment modality, such as adjuvant chemotherapy. Concurrently, high postoperative serum CEA levels are also related to postoperative relapse, especially liver metastases in previous investigations [13, 15] , which may also contribute to the prognosis. Slentz et al also suggested that an initially elevated CEA level that fails to fall to normal in the early postoperative period following curative resection may represent an additional relevant risk factor [16] . Therefore, consideration of prognosis should include postoperative serum CEA levels and TNM stage. The current investigation found that 48.5% of CRC patients with abnormal preoperative serum CEA continued to have high serum CEA postoperatively. Furthermore, the results of multivariate analysis indicated that both lymph node metastases and postoperative serum CEA levels are independent prognostic factors in CRC patients with abnormal levels of preoperative serum CEA. High postoperative serum CEA levels seem to be more powerful than lymph node metastases in predicting prognosis, with a relative risk of 3.161. Although high preoperative serum CEA levels were demonstrated to be associated with an inferior clinical outcome, postoperative serum CEA levels returning to normal predict a better prognosis [16, 17] . Moreover, patients who continue to have high postoperative serum CEA may require more intensive follow-up and treatment, even in patients with stage I or II disease for which adjuvant chemotherapy is conventionally considered unnecessary or controversial [18] [19] [20] . However, this presumption needs further investigation in a larger patient population with long-term follow-up.
In conclusion, the measurement of postoperative serum CEA levels in CRC patients with abnormal preoperative serum CEA levels after curative resection is potentially beneficial in clinical practice. The failure of conversion of abnormal preoperative serum CEA level to normal is an important indicator of poor prognosis. 
